News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
ImClone Systems Corporation Founder Waksal Forming New Biotech Venture
February 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (TheStreet) -- Samuel Waksal, the former CEO of ImClone Systems whose insider stock tips landed him and friend Martha Stewart in federal prison, is getting back into biotech in a big way.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Startups
MORE ON THIS TOPIC
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
May 22, 2025
·
2 min read
·
Annalee Armstrong
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
May 22, 2025
·
2 min read
·
Tristan Manalac
Government
RFK Claims Ignorance About HHS Research, Clinical Trial Cuts in Hearing
May 21, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
New Details From Trump’s Drug Pricing Effort Put Branded Drugs in the Crosshairs
May 20, 2025
·
1 min read
·
Annalee Armstrong
